Global Biomarker Technology Industry

Global Biomarker Technology Industry Research & Trends Analysis Report

Global Biomarker Technology Industry

Global Biomarker Technology Industry Research & Trends Analysis Report


Discover the latest insights into the booming Biomarker Technology Market. This report analyzes market size, growth trends (CAGR 10.2), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for 2024-.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Research Study, the global market for Biomarker Technology should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Biomarker Technology market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Biomarker Technology market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Polymerase Chain Reaction(PCR) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Biomarker Technology include Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding and Siemens Healthcare, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Biomarker Technology.
Report Highlights:

(1) Global Biomarker Technology market size (value), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global Biomarker Technology market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Biomarker Technology market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Biomarker Technology segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Biomarker Technology segment by type and by application and regional segment by type and by application.

(6) Biomarker Technology industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Polymerase Chain Reaction(PCR)

Next Generation Sequencing(NGS)

Immunoassay

Others

Market segment by application, can be divided into

Cancer

Infectious Diseases

Auoimmune Disorders

Cardiovascular Disorders

Others

Market segment by players, this report covers

Abbott Laboratories

Quanterix

Bio-Rad Laboratories

Epigenomics

Agilent Technologies

Johnson & Johnson

Qiagen

Roche Holding

Siemens Healthcare

Myriad Genetics

1 Market Overview

1.1 Product Overview and Scope of Biomarker Technology

1.2 Global Biomarker Technology Market Size and Forecast

1.3 China Biomarker Technology Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Biomarker Technology Share in Global Market, 2019-2030

1.4.2 Biomarker Technology Market Size: China VS Global, 2019-2030

1.5 Biomarker Technology Market Dynamics

1.5.1 Biomarker Technology Market Drivers

1.5.2 Biomarker Technology Market Restraints

1.5.3 Biomarker Technology Industry Trends

1.5.4 Biomarker Technology Industry Policy

2 Global Competitive Situation by Company

2.1 Global Biomarker Technology Revenue by Company (2019-2024)

2.2 Global Biomarker Technology Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Biomarker Technology Concentration Ratio

2.4 Global Biomarker Technology Mergers & Acquisitions, Expansion Plans

2.5 Global Biomarker Technology Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Biomarker Technology Revenue by Company (2019-2024)

3.2 China Biomarker Technology Biomarker Technology Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Biomarker Technology, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Biomarker Technology Industry Chain

4.2 Biomarker Technology Upstream Analysis

4.3 Biomarker Technology Midstream Analysis

4.4 Biomarker Technology Downstream Analysis

5 Sights by Type

5.1 Biomarker Technology Classification

5.1.1 Polymerase Chain Reaction(PCR)

5.1.2 Next Generation Sequencing(NGS)

5.1.3 Immunoassay

5.1.4 Others

5.2 By Type, Global Biomarker Technology Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Biomarker Technology Revenue, 2019-2030

6 Sights by Application

6.1 Biomarker Technology Segment by Application

6.1.1 Cancer

6.1.2 Infectious Diseases

6.1.3 Auoimmune Disorders

6.1.4 Cardiovascular Disorders

6.1.5 Others

6.2 By Application, Global Biomarker Technology Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Biomarker Technology Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Biomarker Technology Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Biomarker Technology Market Size, 2019-2030

7.3 North America

7.3.1 North America Biomarker Technology Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Biomarker Technology Market Size Market Share

7.4 Europe

7.4.1 Europe Biomarker Technology Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Biomarker Technology Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Biomarker Technology Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Biomarker Technology Market Size Market Share

7.6 South America

7.6.1 South America Biomarker Technology Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Biomarker Technology Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Biomarker Technology Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Biomarker Technology Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Biomarker Technology Market Size, 2019-2030

8.3.2 By Company, U.S. Biomarker Technology Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Biomarker Technology Revenue Market Share, 2024 VS 2030

8.3.4 By Application, U.S. Biomarker Technology Revenue Market Share, 2024 VS 2030

8.4 Europe

8.4.1 Europe Biomarker Technology Market Size, 2019-2030

8.4.2 By Company, Europe Biomarker Technology Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Biomarker Technology Revenue Market Share, 2024 VS 2030

8.4.4 By Application, Europe Biomarker Technology Revenue Market Share, 2024 VS 2030

8.5 China

8.5.1 China Biomarker Technology Market Size, 2019-2030

8.5.2 By Company, China Biomarker Technology Revenue Market Share, 2019-2024

8.5.3 By Type, China Biomarker Technology Revenue Market Share, 2024 VS 2030

8.5.4 By Application, China Biomarker Technology Revenue Market Share, 2024 VS 2030

8.6 Japan

8.6.1 Japan Biomarker Technology Market Size, 2019-2030

8.6.2 By Company, Japan Biomarker Technology Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Biomarker Technology Revenue Market Share, 2024 VS 2030

8.6.4 By Application, Japan Biomarker Technology Revenue Market Share, 2024 VS 2030

8.7 South Korea

8.7.1 South Korea Biomarker Technology Market Size, 2019-2030

8.7.2 By Company, South Korea Biomarker Technology Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Biomarker Technology Revenue Market Share, 2024 VS 2030

8.7.4 By Application, South Korea Biomarker Technology Revenue Market Share, 2024 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Biomarker Technology Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Biomarker Technology Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Biomarker Technology Revenue Market Share, 2024 VS 2030

8.8.4 By Application, Southeast Asia Biomarker Technology Revenue Market Share, 2024 VS 2030

8.9 India

8.9.1 India Biomarker Technology Market Size, 2019-2030

8.9.2 By Company, India Biomarker Technology Revenue Market Share, 2019-2024

8.9.3 By Type, India Biomarker Technology Revenue Market Share, 2024 VS 2030

8.9.4 By Application, India Biomarker Technology Revenue Market Share, 2024 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Biomarker Technology Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Biomarker Technology Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Biomarker Technology Revenue Market Share, 2024 VS 2030

8.10.4 By Application, Middle East & Asia Biomarker Technology Revenue Market Share, 2024 VS 2030

9 Global Manufacturers Profile

9.1 Abbott Laboratories

9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

9.1.2 Abbott Laboratories Company Profile and Main Business

9.1.3 Abbott Laboratories Biomarker Technology Models, Specifications and Application

9.1.4 Abbott Laboratories Biomarker Technology Revenue and Gross Margin, 2019-2024

9.1.5 Abbott Laboratories Recent Developments

9.2 Quanterix

9.2.1 Quanterix Company Information, Head Office, Market Area and Industry Position

9.2.2 Quanterix Company Profile and Main Business

9.2.3 Quanterix Biomarker Technology Models, Specifications and Application

9.2.4 Quanterix Biomarker Technology Revenue and Gross Margin, 2019-2024

9.2.5 Quanterix Recent Developments

9.3 Bio-Rad Laboratories

9.3.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

9.3.2 Bio-Rad Laboratories Company Profile and Main Business

9.3.3 Bio-Rad Laboratories Biomarker Technology Models, Specifications and Application

9.3.4 Bio-Rad Laboratories Biomarker Technology Revenue and Gross Margin, 2019-2024

9.3.5 Bio-Rad Laboratories Recent Developments

9.4 Epigenomics

9.4.1 Epigenomics Company Information, Head Office, Market Area and Industry Position

9.4.2 Epigenomics Company Profile and Main Business

9.4.3 Epigenomics Biomarker Technology Models, Specifications and Application

9.4.4 Epigenomics Biomarker Technology Revenue and Gross Margin, 2019-2024

9.4.5 Epigenomics Recent Developments

9.5 Agilent Technologies

9.5.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position

9.5.2 Agilent Technologies Company Profile and Main Business

9.5.3 Agilent Technologies Biomarker Technology Models, Specifications and Application

9.5.4 Agilent Technologies Biomarker Technology Revenue and Gross Margin, 2019-2024

9.5.5 Agilent Technologies Recent Developments

9.6 Johnson & Johnson

9.6.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.6.2 Johnson & Johnson Company Profile and Main Business

9.6.3 Johnson & Johnson Biomarker Technology Models, Specifications and Application

9.6.4 Johnson & Johnson Biomarker Technology Revenue and Gross Margin, 2019-2024

9.6.5 Johnson & Johnson Recent Developments

9.7 Qiagen

9.7.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.7.2 Qiagen Company Profile and Main Business

9.7.3 Qiagen Biomarker Technology Models, Specifications and Application

9.7.4 Qiagen Biomarker Technology Revenue and Gross Margin, 2019-2024

9.7.5 Qiagen Recent Developments

9.8 Roche Holding

9.8.1 Roche Holding Company Information, Head Office, Market Area and Industry Position

9.8.2 Roche Holding Company Profile and Main Business

9.8.3 Roche Holding Biomarker Technology Models, Specifications and Application

9.8.4 Roche Holding Biomarker Technology Revenue and Gross Margin, 2019-2024

9.8.5 Roche Holding Recent Developments

9.9 Siemens Healthcare

9.9.1 Siemens Healthcare Company Information, Head Office, Market Area and Industry Position

9.9.2 Siemens Healthcare Company Profile and Main Business

9.9.3 Siemens Healthcare Biomarker Technology Models, Specifications and Application

9.9.4 Siemens Healthcare Biomarker Technology Revenue and Gross Margin, 2019-2024

9.9.5 Siemens Healthcare Recent Developments

9.10 Myriad Genetics

9.10.1 Myriad Genetics Company Information, Head Office, Market Area and Industry Position

9.10.2 Myriad Genetics Company Profile and Main Business

9.10.3 Myriad Genetics Biomarker Technology Models, Specifications and Application

9.10.4 Myriad Genetics Biomarker Technology Revenue and Gross Margin, 2019-2024

9.10.5 Myriad Genetics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Biomarker Technology Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Biomarker Technology Market trending toward high growth trajectories?
A dynamic process in the Biomarker Technology Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Thermo Fisher, Roche, Bio-Rad, Agilent, Qiagen, Illumina, PerkinElmer, Merck KGaA, Siemens Healthineers, BD.
How are players chosen for the research coverage of the Biomarker Technology Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What are the major applications of the Biomarker Technology Market?
Depending upon the type of applications, the Biomarker Technology Market has been segmented into and other applications.
What is the market value of the Biomarker Technology Industry?
In 2024, the Biomarker Technology Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
Is further segmentation possible given the scope of the Biomarker Technology Market study?
Yes, the add-on segmentation is available in the premium customised version of the Biomarker Technology Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
What are the primary data sources used to evaluate the Biomarker Technology Market sizing?
The majority of data for the Biomarker Technology Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.